DeepWork Capital
VC Fund
Orlando, United States
DeepWork Capital is a VC fund in Orlando focused on Software and SaaS. DeepWork Capital, a Florida-based venture capital firm, invests in high-growth early-stage companies in the technology and life science sectors through proprietary and public committed capital funds. The Firm partners with visionary entrepreneurs building world-changing companies and supports portfolio companies' successes with activeengagement. For additional information, please see https://www.deepworkcapital.com.
- Total investments:
- 92
- Last investment:
- Lead investor:
- 35%
- Fund size:
- $100M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries DeepWork Capital invests in
Stages DeepWork Capital invests in
Countries DeepWork Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 8 contacts → | |||
Round size
- Seed
- $1M–$12M
- Series A
- $1M–$15M
- Series B
- $5.5M–$250M
Investment Focus
Industry
- Software 16 (17%)
- SaaS 10 (11%)
- Health Care 10 (11%)
- Medical 7 (8%)
- FinTech 6 (7%)
Stage
- Seed 27 (29%)
- Series A 21 (23%)
- Series B 8 (9%)
- Funding Round 6 (7%)
- Convertible Note 4 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Benjamin Patz
Co-founder and Managing Partner
|
Co-founder and Managing Partner | Total investments: 17 | Find email | |
Jackson Streeter
Partner
|
Partner | Total investments: 4 | Find email | |
Kathy Chiu
Co-founder and General Managing Partner
|
Co-founder and General Managing Partner | Total investments: 7 | Find email | |
Mitchel Laskey
Co-Founder and Managing General Partner
|
Co-Founder and Managing General Partner | Total investments: 23 | Find email | |
Kenneth Hall
Vice President
|
Vice President | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Biota
|
Biota is a data science company that offers wastewater testing, monitoring and tracking of sources of pollutants, and analytical solutions. | $3M / Seed / Jul 28, 2026 | |
Kalogon
|
Kalogon is the trailblazer in smart seating, best known for developing innovative solutions that reduce the stresses of sitting and improve seated health. Serving healthcare, defense, and aviation, Kalogon’s patent-pending Advanced Pressure Management System (APMS) powers products with adaptive customizations, ambient adjustments, and personalizedsettings to enhance comfort, restore blood flow, and reduce fatigue for those who sit for extended periods.With four Medicare-coded products on the market, Kalogon leverages its core technologies and user-centered design process to create a strong market fit across multiple industries. Beyond healthcare, Kalogon partners with the U.S. Air Force and leading aviation clients to adapt its technologies for demanding environments, improving comfort, sustaining performance, and promoting healthy seated living. Headquartered in Melbourne, Florida and founded in 2019, Kalogon is on a mission to eliminate the stresses of sitting. | $5.8M / Series A / Jun 04, 2026 | |
TENEX.AI
|
TENEX.AI is an automation-first security company designed for the AI-driven era. By leveraging cutting-edge artificial intelligence, TENEX.AI automates and enhances security measures to protect digital assets, networks, and data. Their solutions are built to address modern threats in real-time, providing proactive defense and rapid response. As thelandscape of cyber threats evolves, TENEX.AI ensures businesses stay one step ahead with intelligent, automated security solutions that minimize risks and maximize protection. | $250M / Series B / Mar 31, 2026 | |
FirmPilot
|
FirmPilot develops an AI-driven marketing engine designed for law firms. It automatically generates content and SEO to outrank competitors and get more clients. | $22M / Series A / Feb 26, 2026 | |
Irys Insurtech
|
Irys was created to incorporate technology into our everyday human interactons. Irys is a modular management system that is fundamentally altering the way agents, brokers, and MGAs view their clients and company. | $12.5M / Seed / Oct 13, 2025 | |
Circuitry.ai
|
Circuitry.ai enables manufacturers of complex products to optimize sales and service outcomes with AI-powered decisions. Circuitry.ai decision intelligence platform and Enterprise AI as a Service applications help marketing, sales, and service teams to analyze, augment, and automate impactful and repeat decisions. Circuitry.ai's uniquedecision models are trained on product knowledge, lifecycle transactions, and real-time connected product data to improve the quality, velocity, and consistency of decisions. Using our unique and innovative decision circuits, manufacturers, distributors, and their channel partners can grow sales, increase productivity, and enhance customer experience. | Seed / Oct 01, 2025 | |
|
TENEX.AI
|
TENEX.AI is an automation-first security company designed for the AI-driven era. By leveraging cutting-edge artificial intelligence, TENEX.AI automates and enhances security measures to protect digital assets, networks, and data. Their solutions are built to address modern threats in real-time, providing proactive defense and rapid response. As thelandscape of cyber threats evolves, TENEX.AI ensures businesses stay one step ahead with intelligent, automated security solutions that minimize risks and maximize protection. | $27M / Series A / Sep 11, 2025 | |
Palla
|
Palla is a REST API that lets banks empower their customers to request, receive and manage international inward remittances. Its product is built to allow its partners to fully customize the experience within their app and includes tailored reporting to drive customer insights and engagement. | $14.5M / Series A / May 28, 2025 | |
Worth AI
|
Worth AI is a SaaS platform that leverages AI to enable inclusive financial underwriting. The company streamlines any operations by consolidating platforms, leading to faster approvals, improved compliance, and smarter risk management. | $20M / Seed / Mar 11, 2025 | |
Myosin Therapeutics
|
Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications for CNS-based disorders. The company specializes in molecular machines that turn energy into mechanical work inside cells, enabling doctors to treat various disease states, including cancer, and focuses on developing innovative drugs that target cellularmotor proteins. | $3M / Seed / Feb 26, 2025 | |
| See all 92 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does DeepWork Capital invest in?
DeepWork Capital invests primarily in Software, SaaS and Health Care startups, most often at Seed and Series A stage. Most of the 92 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is DeepWork Capital's check size?
DeepWork Capital typically joins rounds of $1M–$12M at Seed, $1M–$15M at Series A and $5.5M–$250M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds DeepWork Capital participates in.
How do I contact DeepWork Capital?
Public channels for DeepWork Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at DeepWork Capital?
The team at DeepWork Capital includes Benjamin Patz (Co-founder and Managing Partner), Jackson Streeter (Partner) and Kathy Chiu (Co-founder and General Managing Partner), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
